More Amyloid plaque antibodies. That house of cards is going to collapse suddenly I think.
It does show how important in depth data analysis is. Anavex is collecting a huge amount of data in the Rett trials and the AD trial. That should provide many opportunities to find something that the FDA likes
Roche is one of the most powerful BP going, so now that they are driving amyloid thesis, it will likely continue to dominate. FDA all in on amyloid.
Lack of real data proving alz efficacy killing stock price. We get a bear market and this will be under $10 again.
PATIENCE!
Anavex is collecting a huge amount of data in the Rett trials and the AD trial. That should provide many opportunities to find something that the FDA likes
Pray they will listen, as the people who pay their salaries will be flooding them with amyloid trial data.
Market Data 
Markets 
AI
